Tourmaline Bio Inc (TRML): Total Asset Value of Company
This chart confirms the commitment of Tourmaline Bio, Inc. (TRML) management to rapidly implement treatment programs for autoimmune pathologies, while total assets reach 307.08. The business model relies on optimized logistics and the distribution of production capacities to protect margins. Simultaneously, Tourmaline Bio, Inc. (TRML) is developing unique immunological agents for rare diagnoses, which eliminates aggressive price competition for market share at the current stage.
Comprehensive metric breakdowns and analytics for Tourmaline Corp (TRML)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:TRML, tourmalinebio.com
Total assets represent the aggregate volume of the firm's resources and liabilities, calculated inversely via ROA to assess the stability of the financial base. Analyzing fluctuations in assets and resources determines the ability of Tourmaline Bio, Inc. (TRML) to sustain drug development amidst regulatory risks and fierce competition in the immunology segment, where any trial delays could impair accumulated capital.
Competitors of Tourmaline Bio, Inc. (TRML)
ARGX (argenx.com) - Aggregate Company Assets|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Precigen Corp - Company Total Asset Base|PHAR: Aggregate Company Assets|NKTR: Cumulative Company Assets|UPB (Upstream Bio) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|IMNM (Immunome Corp) - Cumulative Company Assets|Company Total Assets GOSS|Aggregate Company Assets KalVista Pharmaceuticals KALV|Total Business Assets septerna.com (SEPN)|PVLA: Company Total Assets|SVRA - Company Assets|Cumulative Company Assets Rigel Pharmaceuticals Inc RIGL|ANAB: Aggregate Business Assets|Aggregate Company Assets ATXS|Company Assets engene.com|RAPT (RAPT Therapeutics) - Cumulative Company Assets|Company Total Assets JBIO|Aclaris (ACRS) - Aggregate Company Assets|Aggregate Asset Value KYTX (Kyverna Therapeutics, Inc)|Tiziana Life Sciences - Aggregate Company Assets|Cumulative Company Assets cabalettabio.com CABA|Ventyx Biosciences, Inc. - Company Total Assets|THTX: Company Total Assets|Avalo Therapeutics Inc. (AVTX) - Aggregate Company Assets|Eledon Pharmaceuticals, Inc (ELDN) - Aggregate Company Assets|AGEN: Company Total Assets|Company Total Asset Base CLYM|Aggregate Company Assets Zura Bio ZURA|Total Business Assets aTyr Pharma Inc (ATYR)|ADAG: Company Total Assets|IMA - Company Assets|Cumulative Company Assets Shattuck Therapeutics (STTK)|EQ - Aggregate Asset Value|connectbiopharm.com (CNTB) - Company Total Assets|Immunic (IMUX) - Aggregate Company Assets|ATRA: Company Total Assets|Company Total Asset Base IFRX|X4 Pharmaceuticals - Aggregate Company Assets|Company Assets adicetbio.com ACET|Cumulative Company Assets Celularity|Aggregate Asset Value INmune Bio Inc INMB|Company Total Assets BRNS (Barinthus Bio)|KZR: Company Total Asset Base|Aggregate Company Assets SAB Biotherapeutics|akaritx.com (AKTX) - Total Business Assets|Company Total Assets ENLV|Cumulative Company Assets Q32 Bio Corp (QTTB)|GOVX (GeoVax Labs Inc) - Cumulative Company Assets|Company Total Asset Base Edesa Biotech Corp EDSA|Cumulative Company Assets iBio, Inc. (IBIO)|Carisma Therapeutics Inc - Aggregate Business Assets|Aggregate Company Assets XTL Biopharmaceuticals Ltd. (XTLB)|BOLT: Aggregate Asset Value|HCWB (hcwbiologics.com) - Aggregate Company Assets|APVO (Aptevo Therapeutics Inc.) - Cumulative Company Assets|Aggregate Company Assets AIM ImmunoTech Inc.|Aggregate Company Assets ADTX|GRI - Aggregate Company Assets|Total Asset Value of Company XORTX Therapeutics Inc (XRTX)|Company Total Assets ReShape Lifesciences|Aggregate Asset Value Revelation Biosciences Corp REVB|Indaptus Therapeutics - Company Total Assets|SCNI: Company Total Assets|Aggregate Company Assets calcimedica.com CALI|AFMD (Affimed N.V.) - Aggregate Asset Value|Aggregate Company Assets ALLK|Cumulative Company Assets HOOKIPA|Company Total Assets IGMS|Company Total Assets iteostherapeutics.com ITOS|Cumulative Company Assets Ocean Biomedical|Aggregate Asset Value TC BioPharm (Holdings) Plc TCBP|Company Total Assets THRD (Third Harmonic Bio, Inc)